FDA Warning Wire: Wockhardt Again In FDA Crosshairs
The U.S. Food and Drug Administration once again scolded drugmaker Wockhardt for testing and record-keeping issues at a subsidary's plant, an issue that's caused trouble for the drugmaker in the past,...To view the full article, register now.
Already a subscriber? Click here to view full article